GoodRx Holdings, Inc.GDRX
時価総額
$9.9億
PER
処方薬の価格比較・割引プラットフォームの米国大手。処方取引、Gold定額、医療者向けProvider Modeを展開。2022年4月にvitaCareを約1.32億ドルで買収。米国中心に展開。
| 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Revenue | 551 | 745 | 767 | 750 | 792 |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | 30 | 47 | 65 | 67 | 48 |
| Research and Development Expense | 62 | 126 | 143 | 136 | 124 |
| Sales and marketing | 255 | 370 | 358 | 341 | 367 |
| General and administrative | 461 | 155 | 145 | 126 | 118 |
| Depreciation and amortization | 18 | 35 | 54 | 108 | 70 |
| Total costs and operating expenses | 826 | 732 | 765 | 777 | 726 |
| Operating income (loss) | -276 | 13 | 2 | -27 | 66 |
| Other expense | 0 | - | - | -4 | -3 |
| Loss on extinguishment of debt | - | - | - | - | -2 |
| Interest income | 0 | 0 | 9 | 32 | 23 |
| Interest expense | - | - | - | - | 53 |
| Total other expense, net | -28 | -24 | -25 | -29 | -34 |
| Income (loss) before income taxes | -303 | -10 | -23 | -56 | 31 |
| Income tax (expense) benefit | -10 | 15 | 10 | -47 | 15 |
| Net income (loss) | -294 | -25 | -33 | -9 | 16 |
| Basic (in usd per share) | -1.07 | -0.06 | -0.08 | -0.02 | 0.04 |
| Diluted (in usd per share) | -1.07 | -0.06 | -0.08 | -0.02 | 0.04 |
| Cost of revenue | 0 | 1 | 0 | 1 | 0 |
| Product development and technology | 11 | 35 | 35 | 30 | 25 |
| Sales and marketing | 9 | 21 | 21 | 20 | 33 |
| General and administrative | 377 | 104 | 64 | 54 | 41 |